Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-κ B

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kwon, Ji Woong ^a   Kwon, Hyuk Kwon ^a   Shin, Hyeon Jun ^a   Choi, Yong Min ^a   Anwar, Muhammad Ayaz ^a   Choi, Sangdun ^a  

^a Ajou University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; HISTONE DEACETYLASE 1; LIPOPOLYSACCHARIDE; PROTEIN BINDING; TRANSCRIPTION FACTOR RELA;

ANIMAL; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; METABOLISM; MOUSE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE 1; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PROTEIN BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 84942752940     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14470     Document Type: Article

References (41)

1. Kaisho, T. & Akira, S. Toll-like receptor function and signaling. J Allergy Clin Immunol 117, 979-987, quiz 988 (2006).
2. Krishnan, J., Selvarajoo, K., Tsuchiya, M., Lee, G. & Choi, S. Toll-like receptor signal transduction. Exp Mol Med 39, 421-438 (2007).
3. Basith, S., Manavalan, B., Lee, G., Kim, S. G. & Choi, S. Toll-like receptor modulators: a patent review (2006-2010). Expert Opin Ther Pat 21, 927-944 (2011).
4. Prins, R. M. et al. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity. J Immunol 176, 157-164 (2006).
5. Whitmore, M. M., Li, S., Falo, L., Jr. & Huang, L. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunol Immunother 50, 503-514 (2001).
6. Krishnan, J., Lee, G. & Choi, S. Drugs targeting Toll-like receptors. Arch Pharm Res 32, 1485-1502 (2009).
7. Ghosh, S. & Karin, M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl, S81-96 (2002).
8. Siebenlist, U., Franzoso, G. & Brown, K. Structure, regulation and function of NF-kappaB. Annu Rev Cell Biol 10, 405-455 (1994).
9. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D. & Miyamoto, S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 9, 2723-2735 (1995).
10. Hayden, M. S. & Ghosh, S. Signaling to NF-kappaB. Genes Dev 18, 2195-2224 (2004).
11. Tak, P. P. & Firestein, G. S. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107, 7-11 (2001).
12. Rayet, B. & Gelinas, C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18, 6938-6947 (1999).
13. Gilmore, T. D., Koedood, M., Piffat, K. A. & White, D. W. Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene 13, 1367-1378 (1996).
14. Basith, S., Manavalan, B., Yoo, T. H., Kim, S. G. & Choi, S. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense. Arch Pharm Res 35, 1297-1316 (2012).
15. Gilmore, T. D. The Rel/NF-kappaB signal transduction pathway: introduction. Oncogene 18, 6842-6844 (1999).
16. Basith, S., Manavalan, B., Gosu, V. & Choi, S. Evolutionary, structural and functional interplay of the IkappaB family members. PloS one 8, e54178 (2013).
17. Thompson, J. E., Phillips, R. J., Erdjument-Bromage, H., Tempst, P. & Ghosh, S. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappaB. Cell 80, 573-582 (1995).
18. Whiteside, S. T., Epinat, J. C., Rice, N. R. & Israel, A. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J 16, 1413-1426 (1997).
19. Manavalan, B., Basith, S., Choi, Y. M., Lee, G. & Choi, S. Structure-function relationship of cytoplasmic and nuclear IkappaB proteins: an in silico analysis. PloS one 5, e15782 (2010).
20. Nolan, G. P. et al. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NFkappa B p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 13, 3557-3566 (1993).
21. Baldwin, A. S., Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14, 649-683 (1996).
22. Whitmore, M. M. et al. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J Immunol 179, 3622-3630 (2007).
23. Hai, T. & Hartman, M. G. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273, 1-11 (2001).
24. Kim, E. Y. et al. ATF3 plays a key role in Kdo2-lipid A-induced TLR4-dependent gene expression via NF-kappaB activation. PloS one 5, e14181 (2010).
25. Chen, B. P., Liang, G., Whelan, J. & Hai, T. ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem 269, 15819-15826 (1994).
26. Drysdale, B. E., Howard, D. L. & Johnson, R. J. Identification of a lipopolysaccharide inducible transcription factor in murine macrophages. Mol Immunol 33, 989-998 (1996).
27. Farber, J. M. A collection of mRNA species that are inducible in the RAW 264.7 mouse macrophage cell line by gamma interferon and other agents. Mol Cell Biol 12, 1535-1545 (1992).
28. Gilchrist, M. et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441, 173-178 (2006).
29. Moon, K. Y., Hahn, B. S., Lee, J. & Kim, Y. S. A cell-based assay system for monitoring NF-kappaB activity in human HaCat transfectant cells. Anal Biochem 292, 17-21 (2001).
30. Libermann, T. A. & Baltimore, D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10, 2327-2334 (1990).
31. Xie, Q. W., Kashiwabara, Y. & Nathan, C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269, 4705-4708 (1994).
32. Anwar, M. A., Panneerselvam, S., Shah, M. & Choi, S. Insights into the species-specific TLR4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection. Sci Rep 5, 7657 (2015).
33. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
34. Anwar, M. A., Basith, S. & Choi, S. Negative regulatory approaches to the attenuation of Toll-like receptor signaling. Exp Mol Med 45, e11 (2013).
35. Hua, B. et al. A splice variant of stress response gene ATF3 counteracts NF-kappaB-dependent anti-Apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivator. J Biol Chem 281, 1620-1629 (2006).
36. Li, H. F., Cheng, C. F., Liao, W. J., Lin, H. & Yang, R. B. ATF3-mediated epigenetic regulation protects against acute kidney injury. Journal of the American Society of Nephrology: JASN 21, 1003-1013 (2010).
37. Kiernan, R. et al. Post-Activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278, 2758-2766 (2003).
38. Kawane, K., Tanaka, H., Kitahara, Y., Shimaoka, S. & Nagata, S. Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation. Proceedings of the National Academy of Sciences of the United States of America 107, 19432-19437 (2010).
39. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675 (2012).
40. Yoshida, T. et al. ATF3 protects against renal ischemia-reperfusion injury. Journal of the American Society of Nephrology: JASN 19, 217-224 (2008).
41. Park, E. J., Kwon, H. K., Choi, Y. M., Shin, H. J. & Choi, S. Doxorubicin induces cytotoxicity through upregulation of pERKdependent ATF3. PloS one 7, e44990 (2012).